Chesterfield, MO, United States of America

Daniel P Getman

Average Co-Inventor Count = 5.5

ph-index = 17

Forward Citations = 1,183(Granted Patents)

Forward Citations (Not Self Cited) = 736(Sep 21, 2024)

DiyaCoin DiyaCoin 0.21 

Inventors with similar research interests:


Location History:

  • St. Louis, MO (US) (1986 - 1994)
  • Chestertfield, MO (US) (1999 - 2001)
  • Chesterfild, MO (US) (2004)
  • Chesterfield, MO (US) (1995 - 2012)


Years Active: 1986-2012

where 'Filed Patents' based on already Granted Patents

170 patents (USPTO):
2 patents (CIPO):

Title: Daniel P Getman: A Pioneer in Retroviral Protease Inhibitors

Introduction:

Daniel P Getman, based in Chesterfield, MO (US), is a renowned inventor and scientist who has made significant contributions to the field of retroviral protease inhibitors. With an impressive collection of 146 patents to his name, Getman's groundbreaking work revolves around the development of α- and β-amino acid hydroxyethylamino sulfonamides as effective inhibitors of HIV protease.

Latest Patents:

Among his latest patents, Getman has successfully introduced the α- and β-amino acid hydroxyethylamino sulfonamides as potent retroviral protease inhibitors. These compounds display exceptional efficacy in inhibiting HIV protease activity, offering potential advancements in the treatment of HIV and related retroviral infections.

Career Highlights:

Throughout his career, Daniel P Getman has contributed his expertise to notable companies such as G.D. Searle & Company and Monsanto Corporation. His work has paved the way for groundbreaking advancements in the pharmaceutical industry, specifically in the area of retroviral protease inhibitors.

Collaborations:

Getman's innovative contributions have been supported by a network of talented colleagues. Two notable collaborators include Gary A DeCrescenzo and Michael L Vazquez. Their collaborations have led to the successful development and optimization of retroviral protease inhibitors, strengthening the field's ability to combat HIV and other retroviral infections.

Conclusion:

Daniel P Getman's prolific career as an inventor and scientist has revolutionized the field of retroviral protease inhibitors. Through his expertise and numerous patents, he has expanded our understanding of HIV treatment possibilities. Getman's contributions, alongside his collaborative efforts, continue to drive advancements in the fight against retroviral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…